Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

8 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Investigation after 24 Wochen (T8) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 24 Wochen (T8), provided that a 3 week interval existed

- 13.09.16 - 1 Formular, 1 Itemgruppe, 36 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 24 Wochen (T8), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Investigation after 21 weeks (T7) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 21 weeks (T7), provided that a 3 week interval existed

- 13.09.16 - 1 Formular, 1 Itemgruppe, 37 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 21 weeks (T7), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Investigation after 18 or 24 weeks (T6) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 18 or 24 weeks (T6)

- 13.09.16 - 1 Formular, 1 Itemgruppe, 37 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 18 or 24 weeks (T6), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Investigation after 12 or 16 weeks (T4) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 12 or 16 weeks (T4)

- 13.09.16 - 1 Formular, 1 Itemgruppe, 37 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 12 or 16 weeks (T4), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Investigation after 15 or 20 weeks (T5) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 15 or 20 weeks (T5)

- 13.09.16 - 1 Formular, 1 Itemgruppe, 37 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 15 or 20 weeks (T5), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Investigation after 9 or 12 weeks (T3) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 9 or 12 weeks (T3)

- 13.09.16 - 1 Formular, 1 Itemgruppe, 37 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 9 or 12 weeks (T3), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Investigation after 6 or 8 weeks (T2) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 6 or 8 weeks (T2)

- 13.09.16 - 1 Formular, 1 Itemgruppe, 37 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 6 or 8 weeks (T2), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Investigation after 3 or 4 weeks (T1) VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28 - Investigation after 3 or 4 weeks (T1)

- 13.09.16 - 1 Formular, 1 Itemgruppe, 37 Datenelemente, 1 Sprache
Itemgruppe: Laboratory parameters
Study documentation part: Investigation after 3 or 4 weeks (T1), VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video